AI assistant
Sending…
AGENUS INC — Director's Dealing 2010
Mar 24, 2010
34023_dirs_2010-03-24_1efc7e8a-d995-4403-b5a3-efc17b817411.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-03-22
Reporting Person: DECHAENE TOM (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-03-22 | Stock Option, right to buy | $14 | E | 17200 | Disposed | 2000-03-22 | Common Stock (17200) | Direct |
More from AGENUS INC
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Legal Proceedings Report
2026
Mar 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Jan 26
Major Shareholding Notification
2026
Jan 23